This Week in Nature

In this week's Nature Biotechnology, a team of Dutch scientists report on the use of CRISPR/Cas9 in functional genetic screens for enhancer elements in the human genome. By targeting the genome-editing molecules to transcription factor binding sites in enhancer regions, the investigators were able to identify several functional enhancer elements, with two found to have roles in cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.